Platelet Count Measured Prior to Cancer Development Is a Risk Factor for Future Symptomatic Venous Thromboembolism: The Tromsø Study

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Jensvoll, Hilde ^a   Blix, Kristine ^a   Braekkan, Sigrid K ^a   Hansen, John Bjarne ^a  

^a UNIVERSITY OF TROMSØ   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER PATIENT; CELL INTERACTION; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HAZARD RATIO; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PLATELET LEUKOCYTE INTERACTION; POPULATION RESEARCH; PRECANCER; RISK ASSESSMENT; THROMBOCYTE COUNT; THROMBOCYTOSIS; VENOUS THROMBOEMBOLISM; COMPLICATION; EPIDEMIOLOGY; MIDDLE AGED; NEOPLASMS; NORWAY; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RISK FACTOR; THROMBOCYTE;

BIOLOGICAL MARKER;

AGED; BIOLOGICAL MARKERS; BLOOD PLATELETS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; NORWAY; PLATELET COUNT; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS; VENOUS THROMBOEMBOLISM;

EID: 84898604761     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0092011     Document Type: Article

References (39)

1. Khorana AA (2003) Malignancy, thrombosis and Trousseau: the case for an eponym. J Thromb Haemost 1: 2463-2465.
2. Timp JF, Braekkan SK, Versteeg HH, Cannegieter SC (2013) Epidemiology of cancer-associated venous thrombosis. Blood 122: 1712-1723.
3. Horsted F, West J, Grainge MJ (2012) Risk of venous thromboembolism in patients with cancer: a systematic review and meta-analysis. PLoS Med 9: e1001275.
4. Prandoni P, Lensing AWA, Piccioli A, Bernardi E, Simioni P, et al. (2002) Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis. Blood 100: 3484-3488. (Pubitemid 35303914)
5. Elting LS, Escalante CP, Cooksley C, Avritscher EBC, Kurtin D, et al. (2004) Outcomes and Cost of Deep Venous Thrombosis Among Patients With Cancer. Arch Intern Med 164: 1653-1661. (Pubitemid 39037944)
6. Dav? G, Patrono C (2007) Platelet Activation and Atherothrombosis. New England Journal of Medicine 357: 2482-2494.
7. von Bruhl ML, Stark K, Steinhart A, Chandraratne S, Konrad I, et al. (2012) Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo. J Exp Med.
8. Buergy D, Wenz F, Groden C, Brockmann MA (2012) Tumor-platelet interaction in solid tumors. Int J Cancer 130: 2747-2760.
9. Gay LJ, Felding-Habermann B (2011) Contribution of platelets to tumour metastasis. Nat Rev Cancer 11: 123-134.
10. Ploquin A, Olmos D, Lacombe D, A'Hern R, Duhamel A, et al. (2012) Prediction of early death among patients enrolled in phase I trials: development and validation of a new model based on platelet count and albumin. Br J Cancer 107: 1025-1030.
11. Tsai AW, Cushman M, Rosamond WD, Heckbert SR, Polak JF, et al. (2002) Cardiovascular Risk Factors and Venous Thromboembolism Incidence: The Longitudinal Investigation of Thromboembolism Etiology. Arch Intern Med 162: 1182-1189. (Pubitemid 34522408)
12. van der Bom JG, Heckbert SR, Lumley T, Holmes CE, Cushman M, et al. (2009) Platelet count and the risk for thrombosis and death in the elderly. J Thromb Haemost 7: 399-405.
13. Braekkan SK, Mathiesen EB, Njolstad I, Wilsgaard T, Stormer J, et al. (2010) Mean platelet volume is a risk factor for venous thromboembolism: the Tromso Study, Tromso, Norway. J Thromb Haemost 8: 157-162.
14. Simanek R, Vormittag R, Ay C, Alguel G, Dunkler D, et al. (2010) High platelet count associated with venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS). J Thromb Haemost 8: 114-120.
15. Khorana AA, Francis CW, Culakova E, Lyman GH (2005) Risk factors for chemotherapy-associated venous thromboembolism in a prospective observational study. Cancer 104: 2822-2829. (Pubitemid 41798294)
16. Mandala M, Barni S, Prins M, Labianca R, Tondini C, et al. (2010) Acquired and inherited risk factors for developing venous thromboembolism in cancer patients receiving adjuvant chemotherapy: a prospective trial. Ann Oncol 21: 871-876.
17. Blix K, Jensvoll H, Braekkan SK, Hansen JB (2013) White blood cell count measured prior to cancer development is associated with future risk of venous thromboembolism - the tromso study. PLoS One 8: e73447.
18. Shao B, Wahrenbrock MG, Yao L, David T, Coughlin SR, et al. (2011) Carcinoma mucins trigger reciprocal activation of platelets and neutrophils in a murine model of Trousseau syndrome. Blood 118: 4015-4023.
19. Larsen IK, Smastuen M, Johannesen TB, Langmark F, Parkin DM, et al. (2009) Data quality at the Cancer Registry of Norway: an overview of comparability, completeness, validity and timeliness. Eur J Cancer 45: 1218-1231.
20. Severinsen MT, Johnsen SP, Tjonneland A, Overvad K, Dethlefsen C, et al. (2010) Body height and sex-related differences in incidence of venous thromboembolism: a Danish follow-up study. Eur J Intern Med 21: 268-272.
21. Severinsen MT, Kristensen SR, Johnsen SP, Dethlefsen C, Tjonneland A, et al. (2009) Smoking and venous thromboembolism: a Danish follow-up study. J Thromb Haemost 7: 1297-1303.
22. Rothman KJ (1976) The estimation of synergy or antagonism. Am J Epidemiol 103: 506-511.
23. Garner C, Tatu T, Reittie JE, Littlewood T, Darley J, et al. (2000) Genetic influences on F cells and other hematologic variables: a twin heritability study. Blood 95: 342-346. (Pubitemid 30017262)
24. Kunicki TJ, Williams SA, Nugent DJ (2012) Genetic variants that affect platelet function. Curr Opin Hematol 19: 371-379.
25. Santimone I, Di Castelnuovo A, De Curtis A, Spinelli M, Cugino D, et al. (2011) White blood cell count, sex and age are major determinants of heterogeneity of platelet indices in an adult general population: results from the MOLI-SANI project. Haematologica 96: 1180-1188.
26. Woller SC, Stevens SM, Jones JP, Lloyd JF, Evans RS, et al. (2011) Derivation and validation of a simple model to identify venous thromboembolism risk in medical patients. Am J Med 124: 947-954 e942.
27. Ho KM, Yip CB, Duff O (2012) Reactive thrombocytosis and risk of subsequent venous thromboembolism: a cohort study. J Thromb Haemost 10: 1768-1774.
28. Salim A, Hadjizacharia P, DuBose J, Kobayashi L, Inaba K, et al. (2009) What is the significance of thrombocytosis in patients with trauma? J Trauma 66: 1349-1354.
29. Kashuk JL, Moore EE, Johnson JL, Biffl WL, Burlew CC, et al. (2010) Progressive postinjury thrombocytosis is associated with thromboembolic complications. Surgery 148: 667-674; discussion 674-665.
30. Merkow RP, Bilimoria KY, McCarter MD, Cohen ME, Barnett CC, et al. (2011) Post-discharge venous thromboembolism after cancer surgery: extending the case for extended prophylaxis. Ann Surg 254: 131-137.
31. Rosendaal FR (1999) Venous thrombosis: a multicausal disease. Lancet 353: 1167-1173. (Pubitemid 29155221)
32. Togna GI, Togna AR, Franconi M, Caprino L (2000) Cisplatin triggers platelet activation. Thromb Res 99: 503-509.
33. Owens AP, 3rd, Mackman N (2011) Microparticles in hemostasis and thrombosis. Circ Res 108: 1284-1297.
34. Nierodzik ML, Karpatkin S (2006) Thrombin induces tumor growth, metastasis, and angiogenesis: Evidence for a thrombin-regulated dormant tumor phenotype. Cancer Cell 10: 355-362. (Pubitemid 44693468)
35. Khorana AA, Kuderer NM, Culakova E, Lyman GH, Francis CW (2008) Development and validation of a predictive model for chemotherapy-associated thrombosis. Blood 111: 4902-4907.
36. Chen M, Geng JG (2006) P-selectin mediates adhesion of leukocytes, platelets, and cancer cells in inflammation, thrombosis, and cancer growth and metastasis. Arch Immunol Ther Exp (Warsz) 54: 75-84. (Pubitemid 44257345)
37. Cerletti C, Tamburrelli C, Izzi B, Gianfagna F, de Gaetano G (2012) Plateletleukocyte interactions in thrombosis. Thromb Res 129: 263-266.
38. Ay C, Simanek R, Vormittag R, Dunkler D, Alguel G, et al. (2008) High plasma levels of soluble P-selectin are predictive of venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS). Blood 112: 2703-2708.
39. Ricos C, Alvarez V, Cava F, Garcia-Lario JV, Hernandez A, et al. (1999) Current databases on biological variation: pros, cons and progress. Scand J Clin Lab Invest 59: 491-500. (Pubitemid 30056739)